267 related articles for article (PubMed ID: 24134793)
1. Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism.
Dotta L; Parolini S; Prandini A; Tabellini G; Antolini M; Kingsmore SF; Badolato R
Orphanet J Rare Dis; 2013 Oct; 8():168. PubMed ID: 24134793
[TBL] [Abstract][Full Text] [Related]
2. Partial albinism with immunodeficiency (Griscelli syndrome).
Klein C; Philippe N; Le Deist F; Fraitag S; Prost C; Durandy A; Fischer A; Griscelli C
J Pediatr; 1994 Dec; 125(6 Pt 1):886-95. PubMed ID: 7996360
[TBL] [Abstract][Full Text] [Related]
3. Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature.
Mancini AJ; Chan LS; Paller AS
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):295-300. PubMed ID: 9486701
[TBL] [Abstract][Full Text] [Related]
4. Chediak-Higashi syndrome: a review of the past, present, and future.
Sharma P; Nicoli ER; Serra-Vinardell J; Morimoto M; Toro C; Malicdan MCV; Introne WJ
Drug Discov Today Dis Models; 2020; 31():31-36. PubMed ID: 33424983
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations.
Meeths M; Bryceson YT; Rudd E; Zheng C; Wood SM; Ramme K; Beutel K; Hasle H; Heilmann C; Hultenby K; Ljunggren HG; Fadeel B; Nordenskjöld M; Henter JI
Pediatr Blood Cancer; 2010 Apr; 54(4):563-72. PubMed ID: 19953648
[TBL] [Abstract][Full Text] [Related]
6. Chediak-Higashi syndrome: Lessons from a single-centre case series.
Carneiro IM; Rodrigues A; Pinho L; de Jesus Nunes-Santos C; de Barros Dorna M; Moschione Castro APB; Pastorino AC
Allergol Immunopathol (Madr); 2019; 47(6):598-603. PubMed ID: 31477396
[TBL] [Abstract][Full Text] [Related]
7. Chediak-Higashi syndrome: Lysosomal trafficking regulator domains regulate exocytosis of lytic granules but not cytokine secretion by natural killer cells.
Gil-Krzewska A; Wood SM; Murakami Y; Nguyen V; Chiang SCC; Cullinane AR; Peruzzi G; Gahl WA; Coligan JE; Introne WJ; Bryceson YT; Krzewski K
J Allergy Clin Immunol; 2016 Apr; 137(4):1165-1177. PubMed ID: 26478006
[TBL] [Abstract][Full Text] [Related]
8. Skin fibroblasts from individuals with Chediak-Higashi Syndrome (CHS) exhibit hyposensitive immunogenic response.
Wang L; Kantovitz KR; Cullinane AR; Nociti FH; Foster BL; Roney JC; Tran AB; Introne WJ; Somerman MJ
Orphanet J Rare Dis; 2014 Dec; 9():212. PubMed ID: 25528552
[TBL] [Abstract][Full Text] [Related]
9. Partial Oculocutaneous Albinism: Two Siblings with Features of both Hermansky Pudlak and Waardenburg's Syndrome.
Ishaq M; Niazi MK; Khan MS; Nadeem Y
J Coll Physicians Surg Pak; 2015 Apr; 25 Suppl 1():S43-4. PubMed ID: 25933462
[TBL] [Abstract][Full Text] [Related]
10. Syndromic albinism: a review of genetics and phenotypes.
Scheinfeld NS
Dermatol Online J; 2003 Dec; 9(5):5. PubMed ID: 14996378
[TBL] [Abstract][Full Text] [Related]
11. Biallelic mutations in AP3D1 cause Hermansky-Pudlak syndrome type 10 associated with immunodeficiency and seizure disorder.
Mohammed M; Al-Hashmi N; Al-Rashdi S; Al-Sukaiti N; Al-Adawi K; Al-Riyami M; Al-Maawali A
Eur J Med Genet; 2019 Nov; 62(11):103583. PubMed ID: 30472485
[TBL] [Abstract][Full Text] [Related]
12. Hermansky-Pudlak syndrome and oculocutaneous albinism in Chinese children with pigmentation defects and easy bruising.
Power B; Ferreira CR; Chen D; Zein WM; O'Brien KJ; Introne WJ; Stephen J; Gahl WA; Huizing M; Malicdan MCV; Adams DR; Gochuico BR
Orphanet J Rare Dis; 2019 Feb; 14(1):52. PubMed ID: 30791930
[TBL] [Abstract][Full Text] [Related]
13. An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.
Gil-Krzewska A; Saeed MB; Oszmiana A; Fischer ER; Lagrue K; Gahl WA; Introne WJ; Coligan JE; Davis DM; Krzewski K
J Allergy Clin Immunol; 2018 Sep; 142(3):914-927.e6. PubMed ID: 29241728
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
Ullah MI
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects.
Lorenzi L; Tabellini G; Vermi W; Moratto D; Porta F; Notarangelo LD; Patrizi O; Sozzani S; de Saint Basile G; Latour S; Pace D; Lonardi S; Facchetti F; Badolato R; Parolini S
PLoS One; 2013; 8(11):e80131. PubMed ID: 24302998
[TBL] [Abstract][Full Text] [Related]
16. [A hemophagocytic syndrome revealing a Griscelli syndrome type 2].
Jennane S; El Kababri M; Hessissen L; Kili A; Nachef MN; Messaoudi N; Doghmi K; Mikdame M; El Khorassani M; Khattab M
Ann Biol Clin (Paris); 2013; 71(4):461-4. PubMed ID: 23906575
[TBL] [Abstract][Full Text] [Related]
17. Novel AP3B1 compound heterozygous mutations in a Japanese patient with Hermansky-Pudlak syndrome type 2.
Nishikawa T; Okamura K; Moriyama M; Watanabe K; Ibusuki A; Sameshima S; Masamoto I; Yamazaki I; Tanita K; Kanekura T; Kanegane H; Suzuki T; Kawano Y
J Dermatol; 2020 Feb; 47(2):185-189. PubMed ID: 31820501
[TBL] [Abstract][Full Text] [Related]
18. [Albinism, thrombopathy, ceroid storage disease--Hermansky-Pudlak syndrome. Overview and description with immunodeficiency].
Berz F; Weiss M; Belohradsky BH
Klin Padiatr; 1996; 208(2):83-7. PubMed ID: 8901188
[TBL] [Abstract][Full Text] [Related]
19. Partial albinism, immunodeficiency, and progressive white matter disease: a new primary immunodeficiency.
Harfi HA; Brismar J; Hainau B; Sabbah R
Allergy Proc; 1992; 13(6):321-8. PubMed ID: 1490625
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
